Cargando…
Prognostic Nomogram for Acute Myeloid Leukemia Patients With Biallelic CEBPA Mutations
Adult acute myeloid leukemia (AML) patients with biallelic mutations of CEBPA (biCEBPA) displays a favorable clinical outcome, and is defined as a unique entity in the 2016 World Health Organization classification. However, due to the intrinsic characteristics of the mutation, existence of co-occurr...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427751/ https://www.ncbi.nlm.nih.gov/pubmed/34513657 http://dx.doi.org/10.3389/fonc.2021.628248 |
_version_ | 1783750235270414336 |
---|---|
author | Xu, Xiaoyu Cai, Wenzhi Cai, Ping Zhang, Ling Yao, Hong Zhang, Tongtong Shen, Hongjie Chen, Suning |
author_facet | Xu, Xiaoyu Cai, Wenzhi Cai, Ping Zhang, Ling Yao, Hong Zhang, Tongtong Shen, Hongjie Chen, Suning |
author_sort | Xu, Xiaoyu |
collection | PubMed |
description | Adult acute myeloid leukemia (AML) patients with biallelic mutations of CEBPA (biCEBPA) displays a favorable clinical outcome, and is defined as a unique entity in the 2016 World Health Organization classification. However, due to the intrinsic characteristics of the mutation, existence of co-occurring mutations and diversified gene expression signature, the prognosis of these patients needs to be analyzed in a more systematic way. In this study we evaluated the genetic characteristics and clinical outcome in a cohort of 137 biCEBPA AML cases, and proposed a prognostic nomogram to predict the overall survival (OS) of based on the clinical variables selected by multivariate Cox regression model in training cohort, including age, white blood cell count, co-existence of DNMT3A and CSF3R mutation and whether patients could achieve complete remission after induction therapy. The area under the receiver operating characteristic (ROC) curves for 3 and 5-year OS were 0.833 and 0.863, respectively. RNA sequencing of 4 relapsed patients showed that over-expression of VMP1 was an indicator of poor prognosis of biCEBPA AML patients. In conclusion, this prognostic nomogram might provide a more accurate prediction of the clinical outcomes of biCEBPA AML patients. |
format | Online Article Text |
id | pubmed-8427751 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84277512021-09-10 Prognostic Nomogram for Acute Myeloid Leukemia Patients With Biallelic CEBPA Mutations Xu, Xiaoyu Cai, Wenzhi Cai, Ping Zhang, Ling Yao, Hong Zhang, Tongtong Shen, Hongjie Chen, Suning Front Oncol Oncology Adult acute myeloid leukemia (AML) patients with biallelic mutations of CEBPA (biCEBPA) displays a favorable clinical outcome, and is defined as a unique entity in the 2016 World Health Organization classification. However, due to the intrinsic characteristics of the mutation, existence of co-occurring mutations and diversified gene expression signature, the prognosis of these patients needs to be analyzed in a more systematic way. In this study we evaluated the genetic characteristics and clinical outcome in a cohort of 137 biCEBPA AML cases, and proposed a prognostic nomogram to predict the overall survival (OS) of based on the clinical variables selected by multivariate Cox regression model in training cohort, including age, white blood cell count, co-existence of DNMT3A and CSF3R mutation and whether patients could achieve complete remission after induction therapy. The area under the receiver operating characteristic (ROC) curves for 3 and 5-year OS were 0.833 and 0.863, respectively. RNA sequencing of 4 relapsed patients showed that over-expression of VMP1 was an indicator of poor prognosis of biCEBPA AML patients. In conclusion, this prognostic nomogram might provide a more accurate prediction of the clinical outcomes of biCEBPA AML patients. Frontiers Media S.A. 2021-08-26 /pmc/articles/PMC8427751/ /pubmed/34513657 http://dx.doi.org/10.3389/fonc.2021.628248 Text en Copyright © 2021 Xu, Cai, Cai, Zhang, Yao, Zhang, Shen and Chen https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Xu, Xiaoyu Cai, Wenzhi Cai, Ping Zhang, Ling Yao, Hong Zhang, Tongtong Shen, Hongjie Chen, Suning Prognostic Nomogram for Acute Myeloid Leukemia Patients With Biallelic CEBPA Mutations |
title | Prognostic Nomogram for Acute Myeloid Leukemia Patients With Biallelic CEBPA Mutations |
title_full | Prognostic Nomogram for Acute Myeloid Leukemia Patients With Biallelic CEBPA Mutations |
title_fullStr | Prognostic Nomogram for Acute Myeloid Leukemia Patients With Biallelic CEBPA Mutations |
title_full_unstemmed | Prognostic Nomogram for Acute Myeloid Leukemia Patients With Biallelic CEBPA Mutations |
title_short | Prognostic Nomogram for Acute Myeloid Leukemia Patients With Biallelic CEBPA Mutations |
title_sort | prognostic nomogram for acute myeloid leukemia patients with biallelic cebpa mutations |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427751/ https://www.ncbi.nlm.nih.gov/pubmed/34513657 http://dx.doi.org/10.3389/fonc.2021.628248 |
work_keys_str_mv | AT xuxiaoyu prognosticnomogramforacutemyeloidleukemiapatientswithbialleliccebpamutations AT caiwenzhi prognosticnomogramforacutemyeloidleukemiapatientswithbialleliccebpamutations AT caiping prognosticnomogramforacutemyeloidleukemiapatientswithbialleliccebpamutations AT zhangling prognosticnomogramforacutemyeloidleukemiapatientswithbialleliccebpamutations AT yaohong prognosticnomogramforacutemyeloidleukemiapatientswithbialleliccebpamutations AT zhangtongtong prognosticnomogramforacutemyeloidleukemiapatientswithbialleliccebpamutations AT shenhongjie prognosticnomogramforacutemyeloidleukemiapatientswithbialleliccebpamutations AT chensuning prognosticnomogramforacutemyeloidleukemiapatientswithbialleliccebpamutations |